Tango Therapeutics, Inc. (TNGX)

NGM – Real vaqt narxi. Valyuta: USD

26.59

+0.25 (0.95%)

Bozor ochiq: Aug 12, 2026, 11:58 AM EDT

26.23

-0.11 (-0.42%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Tango Therapeutics Announces Executive Chair Transition

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Weber, the Executive Chairman of the Board of Directors of Tango Therapeutics, will be stepping down in connection with other pursuits.

03.08.2026

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Tango Therapeutics, Inc. (TNGX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videolar

No Data

Press-relizlar

Tango Therapeutics Announces Executive Chair Transition

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videolar

No Data

Press-relizlar

Tango Therapeutics Announces Executive Chair Transition

Search stocks

Tango Therapeutics, Inc. (TNGX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videolar

No Data

Press-relizlar

Tango Therapeutics Announces Executive Chair Transition

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videolar

No Data

Press-relizlar

Tango Therapeutics Announces Executive Chair Transition